"Premature ejaculation is a frequent and distinct medical condition that can severely impact quality of life, affecting the physical and emotional well-being of patients and their partners," says James H. Barada, M.D., urologist at the Center for Male Sexual Health, Albany, NY, and board member of the Sexual Medicine Society of North America (SMSNA).

Priligy is a serotonin re-uptake inhibitor antidepressant drug, and is currently being tested as a treatment for premature ejaculation in men. The following is our Dapoxetine review using the most current information available. From tomorrow it it will be possible to buy Priligy in Spanish Pharmacies, also known by its full chemical name of Dapoxetine Hydrochloride.

Approved by the AEMPS, dapoxetine hydrochloride would be the first prescription treatment designed specifically to treat PE and will be marketed in Spain. by Jansenn-Cilang, european divison of Johnson & Johnson

According to the American Urological Association, premature ejaculation may be the most common male sexual disorder. It is estimated that PE may affect 27 percent to 34 percent of men across all age ranges, in contrast to erectile dysfunction, which is estimated to affect 10 percent to 12 percent of all men, who are usually older in age. PE can be a lifelong condition experienced from the beginning of sexual activity or can develop after years of satisfactory sexual activity.

The Priligy will be available in two presentations of 30 to 60 milligrams, and cost 11.8 and 15 € respectively per tablet.